References
Moll JM, Wright V: Psoriatic arthritis. Semin Arthritis Rheum 1973, 3:55–78.
Gladman DD: Psoriatic arthritis. In Kelly’s Textbook of Rheumatology, edn 7. Edited by Harris ED, Budd RC, Firestein GS, et al.: Philadelphia: WB Saunders; 2004:1155–1164.
Wright V: Psoriatic arthritis: a comparative study of rheumatoid arthritis and arthritis associated with psoriasis. Arch Deramtol 1959, 80:27–35.
Coulton BL, Thomson K, Symmons DP, Poper AJ: Outcome in patients hospitalized for psoriatic arthritis. Clin Rheumatol 1989, 8:261–265.
Gladman DD, Shuckett R, Russell ML, et al.: Psoriatic arthritis (PSA)—an analysis of 220 patients. Q J Med 1987, 62:127–141.
Kane D, Stafford L, Bresniham B, Fitzgerald O: A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology 2003, 42:1460–1468.
McHugh NJ, Balachrishnan C, Jones SM: Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study. Rheumatology (Oxford) 2003, 42:778–783.
Torre Alonso JC, Rodriguez Perez A, Arribas Castrillo JM, et al.: Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients. Br J Rheumatol 1991, 30:245–250.
Bond SJ, Farewell VT, Schentag CT, Gladman DD: Predictors for radiological damage in psoriatic arthritis. Results from a single centre. Ann Rheum Dis 2007, 66:370–337.
Queiro-Silva R, Torre-Alonso JC, Tinture-Eguren T, Lopez-Lagunas I: A polyarticular onset predicts erosive and deforming disease in psoriatic arthritis. Ann Rheum Dis 2003, 62:68–70.
Kavanaugh A, Antoni CE, Kreuger GG, et al.: Infliximab treatment dissociates the effect of CRP on radiographic progression in patients with psoriatic arthritis. Ann Rheum Dis 2007, 66(Suppl II):417.
Gladman D, Mease PJ, Choy EH, et al.: Analysis of risk factors for radiographic progression in psoriatic arthritis (PsA): subanalysis of ADEPT. Arthritis Rheum 2007, 56(Suppl 9):S257.
Gladman DD, Farewell VT, Husted J, Wong K: Mortality studies in psoriatic arthritis. Results from a single center. II. Prognostic indicators for mortality. Arthritis Rheum 1998, 41:1103–1110.
Ali Y, Tom BD, Schentag CT, et al.: Improved survival in psoriatic arthritis (PsA) with calendar time. Arthritis Rheum 2007, 56:2708–2714.
Sokoll KB, Helliwell PS: Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol 2001, 28:1842–1846.
Gladman DD: Disability and quality of life considerations. Psoriatic Arthritis. In Psoriasis and Psoriatic Arthritis: An. Integrated Approach. Edited by Gordon GB, Ruderman E. Heidelberg, Germany: Springer-Verlag; 2005:118–123.
Husted JA, Tom BD, Farewell VT, et al.: A longitudinal study of the effect of disease activity and clinical damage on physical function over the course of psoriatic arthritis: Does the effect change over time? Arthritis Rheum 2007, 56:840–849.
Gladman DD, Tung NG, Hing E, et al.: Remission in psoriatic arthritis. J Rheumatol 2001, 28:1045–1048.
Soriano ER, McHugh NJ: Therapies for peripheral joint disease in psoriatic arthritis. A systematic review. J Rheumatol 2006, 33:1422–1430.
Mease P: Management of psoriatic arthritis: the therapeutic interface between rheumatology and dermatology. Curr Rheumatol Rep 2006, 8:348–354.
Taylor WJ, Marchesoni A, Arreghini M, et al.: A comparison of the performance characteristics of classification criteria for the diagnosis of psoriatic arthritis. Semin Arthritis Rheum 2004, 34:575–584.
Taylor WJ, Gladman DD, Helliwell PS, et al.: Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006, 54:2665–2673.
Chandran V, Schentag CT, Gladman DD: Sensitivity of the Classification of Psoriatic Arthritis (CASPAR) criteria in early psoriatic arthritis. Arthritis Rheum 2007, 57:1560–1563.
Chandran V, Schentag CT, Gladman DD: Are the CASPAR criteria for psoriatic arthritis accurate when applied to patients attending a family practice clinic? Arthritis Rheum 2006, 54:4091.
Scarpa R, Cuocolo A, Peluso R, et al.: Early psoriatic arthritis: the clinical spectrum. J Rheumatol 2008, 35:137–141.
Peloso PM, Behl M, Hull P, Reeder B: The psoriasis & arthritis questionnaire (PAQ) in detection of arthritis among patients with psoriasis. Arthritis Rheum 1997, 40(Suppl 9):S64.
Alenius GM, Stenberg B, Stenlund H, et al.: Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of psoriatic and arthritic questionnaire. J Rheumatol 2002, 29:2577–2582.
Husni ME, Meyer KH, Cohen DS, et al.: The PASE questionnaire: pilot-testing a psoriatic arthritis screening and evaluation tool. J Am Acad Dermatol 2007, 57:481–487.
Gladman DD, Schentag CT, Tom BD, et al.: Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS). Ann Rheum Dis 2008 (in press).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gladman, D.D. Can we identify psoriatic arthritis early?. Curr Rheumatol Rep 10, 419–421 (2008). https://doi.org/10.1007/s11926-008-0067-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11926-008-0067-9